Year: 2024

JACKSON, Wyo., Nov. 14, 2024 (GLOBE NEWSWIRE) — Brand Engagement Network Inc. (“BEN”) (Nasdaq: BNAI), a global leader in secure and reliable conversational AI solutions, today announced its financial results and key business highlights for the third quarter ended September 30, 2024. “In the third quarter, we made significant progress in delivering secure, scalable AI solutions and advancing our mission to transform industries with intelligent technology,” said Paul Chang, CEO of BEN. “As we look ahead, BEN is poised to accelerate growth and deliver value to our customers, reinforcing our leadership in closed-loop Gen AI.” Q3 2024 Key Business Highlights:KangarooHealth Partnership: BEN partnered with KangarooHealth to enhance remote patient monitoring and chronic care management through AI, aiming to scale...

MINNEAPOLIS, Nov. 14, 2024 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the quarter ended September 30, 2024. As previously announced, management is hosting an earnings call today at 4:30 p.m. ET. Q3 2024 and Recent Highlights:Up to $12.0 million financing commitment secured from strategic investor, Nant Capital. First patient enrolled in a Phase I dose escalation study to evaluate CPP-1X-S (eflornithine sachets) in STK11 mutant non-small cell lung cancer (NSCLC).Jennifer K. Simpson, PhD, MSN, CRNP, President & CEO of Panbela, commented: “The third quarter marked another period of significant advancement for Panbela,...

Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adults Cosibelimab PDUFA goal date of December 28 for potential approval to treat metastatic or locally advanced cutaneous squamous cell carcinoma MIAMI, Nov. 14, 2024 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue, today announced financial results and recent corporate highlights for the third quarter ended September 30, 2024. Lindsay A. Rosenwald, M.D., Fortress’ Chairman, President and Chief Executive Officer, said, “We are thrilled to have received U.S. Food and Drug Administration (“FDA”) approval for Emrosi™,...

Motorsport Games Reports Third Quarter 2024 Financial ResultsMotorsport Games Reports Third Quarter 2024 Financial ResultsMIAMI, Nov. 14, 2024 (GLOBE NEWSWIRE) — Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or “the Company”) today reported financial results for its third quarter ended September 30, 2024. The Company has also posted the third quarter 2024 earnings slides highlighting key milestones that occurred during and subsequent to the period, which are accessible on the Company’s investor relations website. “The business has continued to take useful strides in Q3 2024 with further product updates, business streamlining and in the assessment of undertaking of the previously announced ‘strategic alternatives,’” remarked Stephen Hood, President and Chief Executive Officer of Motorsport Games. “Our second...

PHOENIX, Nov. 14, 2024 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (Cboe CA: TILT) (OTCQB: TLLTF), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, is reporting its financial and operating results for the three months ended September 30, 2024. TILT is also announcing that it is underway with a review of strategic alternatives for its plant-touching business. All financial information is reported in U.S. dollars and prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) unless otherwise indicated. “We are underway with a comprehensive strategic review of our plant-touching business,” announced TILT’s Chief Executive Officer Tim Conder. “This process allows us to evaluate a range...

WILMINGTON, Del., Nov. 14, 2024 (GLOBE NEWSWIRE) — Thunder Power Holdings, Inc. (Nasdaq: AIEV) (“Thunder Power” or the “Company”), a technology innovator and a developer of premium passenger EVs, today announced its unaudited financial results for the three months ended September 30, 2024 (“Third Quarter 2024”). Third Quarter 2024 Financial HighlightsRevenues were nil, consistent with the same period in 2023. Operating expenses were approximately $0.9 million, compared to $0.6 million in the prior year. The changes were primarily attributed to an increase of professional expenses of approximately $0.4 million with the closing of Business Combination and an increase of approximately $0.1 million in insurance expenses for the management of the Company after the business combination, partially net off against a decrease of share-based...

– Topline data in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy anticipated around year-end 2024 MIAMI, Nov. 14, 2024 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today reported financial results and recent corporate highlights for the third quarter ended September 30, 2024. “We have generated considerable momentum this past quarter in advancing our pipeline of innovative treatments for neurologic diseases,” said Alexandra MacLean, M.D., Chief Executive Officer of Avenue. “AJ201 is a potential best-in-class asset that would bring a disease-modifying therapeutic option to patients with significant unmet medical need...

HOUSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) — PrimeEnergy Resources Corporation (NASDAQ: PNRG) announced today net income of $22,076,000 for the quarter, and $53,127,000 for the nine months, ended September 30, 2024. This represents $8.80 and $20.93 per share, on a fully diluted basis, for the three and nine months ended September 30, 2024. As of November 14, 2024, the total outstanding shares including outstanding options are 2,485,000. Oil and gas production volumes for the three months ended September 30, 2024 and 2023:                                 2024   2023   Increase   IncreaseOil production (barrels)   757,000       323,000       434,000       134.37 %Natural gas production (Mcf)   2,144,000       1,081,000       1,063,000       98.41 %Natural gas liquids production (barrels)   394,000       161,000       233,000       144.72 %                               Oil...